Date Range
Date Range
Date Range
Investing in first-in-class cancer therapeutics. ASH 2014 Investor and Analyst Event. Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron Corporation Reports Second Quarter 2015 Financial Results. Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events.
Partnerships, Collaborations and Customer Pipeline. Gevo, ethanol and the future of biofuels. Q2 2015 Gevo, Inc. Q2 2015 Gevo, Inc. Click here to add this event to your calendar. at the Jefferies 2015 Industrials Conference. at the Jefferies 2015 Industrials Conference.
Annual Reports and Proxy Â. E-mail Alerts and RSS Feeds Â. Q2 2015 Gibraltar Earnings Conference Call. Q2 2015 Gibraltar Earnings Conference Call.  Click here to add this event to your calendar. Gibraltar Reports Second-Quarter 2015 Financial Results. Gibraltar Industries Appoints Sharon M. Nish as Directors, Completing Succession Plans. Replication or redistribution of E.
Knowledge Management System Of Guangzhou Institute of Energy Conversion, CAS. Flow rate analysis of compressible superheated s. Transparent optically vanadium dioxide thermochr. Comparison of sodium hydroxide and calcium hydro. Comparative study of surface properties determin. Transesterification of vegetable oil on low cost.